MCK · McKesson Corp
Price
Snapshot
50 fields · last close| Market Cap | $117.2B |
| P/E | 25.51 |
| Float | 117.0M |
| Beta | 0.30 |
| Volatility | 7.6% |
| Exchange | NYSE |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Low |
| Clavix score | 78.7 |
| Price | 1,001.74 |
| Change | −0.31% |
| Prev Close | 1,004.84 |
| Open | 1,012.20 |
| Day Low | 999.27 |
| Day High | 1,014.99 |
| Avg Vol | 1 |
| Avg $ Vol | $691.4M |
| 52W High | 1,014.99 |
| 52W Low | 723.68 |
| 52W Pos | 95.5% |
| From High | −1.31% |
| From Low | +38.42% |
| Max DD 1Y | −27.17% |
| Spread | 0.10% |
| Liquidity | Deep |
| SMA 20 | +9.57% |
| SMA 50 | +11.75% |
| SMA 200 | +17.30% |
| RSI (14) | 75.7 |
| Vol 30D | 26.0% |
| Vol 90D | 29.8% |
| 1Y Range | 724–1,015 |
| Daily bars | 536 |
| Perf Week | +7.03% |
| Perf Month | +14.24% |
| Perf Quarter | +20.85% |
| Perf Half Y | +15.98% |
| Perf Year | +26.88% |
| Perf YTD | +21.65% |
| Prev Day | −0.31% |
| Clavix | B+ |
| Debt / Eq | 1.45 |
| Curr Ratio | 0.85 |
| Int Cover | 29.8× |
| FCF Margin | 1.4% |
| Rev Growth | +12.4% |
| Profit | Profitable |
| Leverage | Moderate |
| Sector rank | 22 / 49 |
What MCK does
McKesson Corporation provides healthcare services in the United States and internationally.
It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers.
It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care.
In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies.
Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers.
McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Clavix risk grade
regraded every trading dayMCK grades B+, 78.7 of 100. Steadiest on News Sentiment (68), most exposed on Price Stability (63, mixed). 3 of the 4 weighted dimensions sit above the Health Care median. Ranks 22 of 49 in Health Care by Clavix score.
How rough the ride is
| MCK | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.30 | 0.84 |
| Volatilityannualized | 7.6% | 20.9% |
| Max drawdown, past yearworst peak-to-trough fall | −27.2% | — |
| Typical daily movemedian absolute daily change | 1.05% | — |
| Days beyond ±3%of the last 252 sessions | 16 (6%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| MCK | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.30 | 0.84 |
| Macro sensitivityrate, dollar and credit exposure bucket | Low | Moderate 53% of 49 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| MCK | |
|---|---|
| 1 week | +7.0% |
| 1 month | +14.2% |
| Year to date | +21.7% |
| 1 year | +26.9% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| MCK | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 25 Aug |
| Average score0 most bearish, 100 most bullish | 55 |
| Bullish · bearisharticles above 60 · below 40 | 19 · 9 |
| Directionarticles whose tone is improving vs worsening | 19 ↑ 9 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.
Growth
| MCK | |
|---|---|
| Revenue growthyear over year | +12.4% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openWall Street Zen raised its rating on McKesson shares from "hold" to "buy" in a report issued on Saturday.
The article argues McKesson is positioned to outperform the broader market, citing above-average growth in its financials and listing three reasons to think so. The body provided is too short to detail what those reasons are.
McKesson and private equity firm Clayton Dubilier & Rice agreed to take Option Care Health private for $32.05 per share in cash, valuing the home-infusion company at about $5.8 billion in total. The article notes Option Care's stock has been trading below the deal price. The body is too short to draw further detail.
McKesson and private equity firm CD&R agreed to acquire Option Care Health (NASDAQ:OPCH) for $32.05 per share.
McKesson and private equity firm CD&R are buying Option Care Health, the largest independent provider of home and alternate-site infusion services in the US, for about $5.8 billion in cash. The deal price of $32.05 per share represents a 37% premium to Option Care's Monday closing price.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| CVS | CVS Health Corp | A- | $118.1B | 24.16 | 0.58 | Compare |
| MDT | Medtronic PLC | A- | $121.2B | 23.16 | 0.59 | Compare |
| SYK | Stryker Corp | B | $113.0B | 30.31 | 0.79 | Compare |
| HCA | HCA Healthcare Inc | B+ | $99.34B | 14.52 | 1.12 | Compare |
| ELV | Elevance Health Inc | B+ | $92.88B | 18.71 | 0.64 | Compare |
| ISRG | Intuitive Surgical Inc | B- | $150.7B | 48.03 | 1.45 | Compare |
| CI | Cigna Group | A- | $79.88B | 12.45 | 0.25 | Compare |
| ABT | Abbott Laboratories | B+ | $181.5B | 33.46 | 0.55 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. 1 month free on iPhone.